SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
02-Oct-24 11:22 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 30-Sep-24 | Payment of Exercise | 4,697 | $0.99 | $4,650.03 | (< 1%) 1.15M to 1.15M | |
02-Oct-24 11:32 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 30-Sep-24 | Payment of Exercise | 343 | $0.99 | $339.57 | (< 1%) 294.51K to 294.17K | |
02-Oct-24 11:44 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 30-Sep-24 | Payment of Exercise | 1,158 | $0.99 | $1,146.42 | (< 1%) 174.5K to 173.34K | |
04-Sep-24 11:26 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 31-Aug-24 | Payment of Exercise | 2,239 | $0.80 | $1,783.14 | (< 1%) 1.15M to 1.15M | |
04-Sep-24 11:36 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 31-Aug-24 | Payment of Exercise | 90 | $0.80 | $71.68 | (< 1%) 294.6K to 294.51K | |
04-Sep-24 11:43 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 31-Aug-24 | Payment of Exercise | 252 | $0.80 | $200.69 | (< 1%) 174.75K to 174.5K | |
02-Aug-24 2:38 PM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 31-Jul-24 | Payment of Exercise | 252 | $0.75 | $189.00 | (< 1%) 175.0K to 174.75K | |
02-Aug-24 2:31 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 31-Jul-24 | Payment of Exercise | 90 | $0.75 | $67.50 | (< 1%) 294.69K to 294.6K | |
02-Aug-24 2:16 PM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 31-Jul-24 | Payment of Exercise | 2,239 | $0.75 | $1,679.25 | (< 1%) 1.16M to 1.15M | |
02-Jul-24 11:00 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 30-Jun-24 | Payment of Exercise | 343 | $0.80 | $274.40 | (< 1%) 295.04K to 294.69K | |
02-Jul-24 11:09 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 30-Jun-24 | Payment of Exercise | 4,697 | $0.80 | $3,757.60 | (< 1%) 1.16M to 1.16M | |
02-Jul-24 11:21 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 30-Jun-24 | Payment of Exercise | 1,158 | $0.80 | $926.40 | (< 1%) 176.16K to 175.0K | |
11-Jun-24 3:34 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 06-Jun-24 | Sale | 2,189 | $0.88 | $1,917.56 | (< 1%) 297.22K to 295.04K | |
07-Jun-24 9:49 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 05-Jun-24 | Sale | 25,800 | $0.88 | $22,662.70 | (8%) 323.02K to 297.22K | |
04-Jun-24 11:24 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 31-May-24 | Payment of Exercise | 2,239 | $0.93 | $2,082.05 | (< 1%) 1.16M to 1.16M | |
04-Jun-24 11:48 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 31-May-24 | Payment of Exercise | 252 | $0.93 | $234.34 | (< 1%) 176.41K to 176.16K | |
04-Jun-24 11:39 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 31-May-24 | Payment of Exercise | 90 | $0.93 | $83.69 | (< 1%) 323.11K to 323.02K | |
02-May-24 9:06 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 30-Apr-24 | Payment of Exercise | 252 | $1.13 | $284.76 | (< 1%) 176.66K to 176.41K | |
02-May-24 8:49 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 30-Apr-24 | Payment of Exercise | 2,239 | $1.13 | $2,530.07 | (< 1%) 1.16M to 1.16M | |
02-May-24 8:57 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 30-Apr-24 | Payment of Exercise | 90 | $1.13 | $101.70 | (< 1%) 323.2K to 323.11K | |
23-Apr-24 9:53 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 21-Apr-24 | Payment of Exercise | 19,673 | $1.15 | $22,623.90 | (2%) 1.18M to 1.16M | |
23-Apr-24 10:09 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 21-Apr-24 | Payment of Exercise | 2,030 | $1.15 | $2,334.50 | (< 1%) 325.23K to 323.2K | |
23-Apr-24 10:21 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 21-Apr-24 | Payment of Exercise | 7,250 | $1.15 | $8,337.50 | (4%) 183.91K to 176.66K | |
02-Apr-24 11:34 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 31-Mar-24 | Payment of Exercise | 2,239 | $1.20 | $2,686.80 | (< 1%) 1.19M to 1.18M | |
02-Apr-24 11:45 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 31-Mar-24 | Payment of Exercise | 90 | $1.20 | $108.00 | (< 1%) 325.32K to 325.23K | |
02-Apr-24 11:52 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 31-Mar-24 | Payment of Exercise | 252 | $1.20 | $302.40 | (< 1%) 184.16K to 183.91K | |
04-Mar-24 2:10 PM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 29-Feb-24 | Payment of Exercise | 252 | $1.21 | $304.92 | (< 1%) 184.41K to 184.16K | |
04-Mar-24 2:01 PM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 29-Feb-24 | Payment of Exercise | 2,239 | $1.21 | $2,709.19 | (< 1%) 1.19M to 1.19M | |
04-Mar-24 1:50 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 29-Feb-24 | Payment of Exercise | 90 | $1.21 | $108.90 | (< 1%) 325.41K to 325.32K | |
21-Feb-24 10:57 AM View: | McClurg Ronald W. Chief Financial Officer | Neuroone Medical Technologi... (NMTC) | 18-Feb-24 | Grant | 113,717 | -- | -- | 87% 130.4K to 244.12K | |
21-Feb-24 10:14 AM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 18-Feb-24 | Grant | 663,497 | -- | -- | 126% 525.49K to 1.19M | |
21-Feb-24 10:44 AM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 18-Feb-24 | Grant | 25,000 | -- | -- | 8% 300.41K to 325.41K | |
21-Feb-24 11:08 AM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 18-Feb-24 | Grant | 101,743 | -- | -- | 123% 82.67K to 184.41K | |
01-Feb-24 1:29 PM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 31-Jan-24 | Payment of Exercise | 2,239 | $1.25 | $2,798.75 | (< 1%) 527.73K to 525.49K | |
01-Feb-24 1:41 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 31-Jan-24 | Payment of Exercise | 90 | $1.25 | $112.50 | (< 1%) 300.5K to 300.41K | |
01-Feb-24 1:51 PM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 31-Jan-24 | Payment of Exercise | 252 | $1.25 | $315.00 | (< 1%) 82.92K to 82.67K | |
03-Jan-24 1:29 PM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 31-Dec-23 | Payment of Exercise | 2,239 | $1.58 | $3,537.62 | (< 1%) 529.97K to 527.73K | |
03-Jan-24 1:29 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 31-Dec-23 | Payment of Exercise | 90 | $1.58 | $142.20 | (< 1%) 300.59K to 300.5K | |
03-Jan-24 1:30 PM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 31-Dec-23 | Payment of Exercise | 252 | $1.58 | $398.16 | (< 1%) 83.18K to 82.92K | |
27-Dec-23 6:08 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 27-Dec-23 | Sale | 31,445 | $1.46 | $45,859.40 | (9%) 332.04K to 300.59K | |
27-Dec-23 6:08 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 26-Dec-23 | Sale | 6,848 | $1.35 | $9,269.45 | (2%) 338.89K to 332.04K | |
26-Dec-23 4:01 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 22-Dec-23 | Sale | 1,800 | $1.40 | $2,520.00 | (< 1%) 340.69K to 338.89K | |
26-Dec-23 4:08 PM View: | Volker Christopher Chief Operating Officer | Neuroone Medical Technologi... (NMTC) | 21-Dec-23 | Purchase | 75,000 | $1.40 | $105,000.00 | 100% 0 to 75.0K | |
26-Dec-23 4:01 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 21-Dec-23 | Sale | 9,907 | $1.40 | $13,869.80 | (3%) 350.59K to 340.69K | |
04-Dec-23 4:32 PM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 30-Nov-23 | Payment of Exercise | 252 | $1.45 | $365.40 | (< 1%) 83.43K to 83.18K | |
04-Dec-23 4:09 PM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 30-Nov-23 | Payment of Exercise | 2,239 | $1.45 | $3,246.55 | (< 1%) 532.21K to 529.97K | |
04-Dec-23 4:24 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 30-Nov-23 | Payment of Exercise | 90 | $1.45 | $130.50 | (< 1%) 350.68K to 350.59K | |
03-Nov-23 3:50 PM View: | Rosa David A CEO and President Director | Neuroone Medical Technologi... (NMTC) | 02-Nov-23 | Payment of Exercise | 2,239 | $1.61 | $3,604.79 | (< 1%) 534.45K to 532.21K | |
03-Nov-23 3:59 PM View: | Christianson Mark Business Development Director | Neuroone Medical Technologi... (NMTC) | 02-Nov-23 | Payment of Exercise | 90 | $1.61 | $144.90 | (< 1%) 350.77K to 350.68K | |
03-Nov-23 4:07 PM View: | Mertens Steve Chief Technology Officer | Neuroone Medical Technologi... (NMTC) | 02-Nov-23 | Payment of Exercise | 252 | $1.61 | $405.72 | (< 1%) 83.68K to 83.43K |